Director Cynthia Burks receives 3,562 RSUs at Inspire Medical (INSP)

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Burks Cynthia reported acquisition or exercise transactions in this Form 4 filing.

Inspire Medical Systems director Cynthia Burks received an equity grant in the form of restricted stock units. She was awarded 3,562 RSUs of common stock at no cash cost, increasing her direct holdings to 6,213 shares.

Each RSU represents a right to receive one share of common stock. The RSUs vest on the earlier of the first anniversary of the grant date or immediately before a Change of Control under the company’s 2018 Incentive Award Plan, subject to her continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Burks Cynthia

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,562	$0.00	--

Holdings After Transaction: Common Stock — 6,213 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSUs granted: 3,562 RSUs Price per RSU: $0.0000 per share Shares after grant: 6,213 shares +1 more

4 metrics

RSUs granted 3,562 RSUs Award of restricted stock units on April 30, 2026

Price per RSU $0.0000 per share Grant price for 3,562 RSUs

Shares after grant 6,213 shares Total common shares directly held after transaction

Vesting trigger First anniversary or pre-Change of Control Earlier of one year from grant or before Change of Control

Key Terms

Restricted Stock Units ("RSUs"), Change of Control, 2018 Incentive Award Plan

3 terms

Restricted Stock Units ("RSUs") financial

"Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Change of Control financial

"earlier to occur of (a) the first anniversary ... or (b) the date that is immediately prior to the occurrence of a Change of Control"

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

2018 Incentive Award Plan financial

"Change of Control (as defined in the Issuer's 2018 Incentive Award Plan)"

Form 4 Insider Transactions: What Each Field Means →

05/04/2026 - 06:21 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burks Cynthia

(Last)

(First)

(Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY

MINNESOTA

55416

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/30/2026		A		3,562⁽¹⁾	A	$0	6,213	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

	/s/ Bryan Phillips, Attorney-in-Fact for Cynthia Burks	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Inspire Medical Systems (INSP) report for Cynthia Burks?

Inspire Medical Systems reported that director Cynthia Burks received a grant of 3,562 restricted stock units. These RSUs increase her direct holdings to 6,213 shares of common stock, reflecting a compensation-related equity award rather than an open-market purchase or sale.

How many Inspire Medical Systems shares does Cynthia Burks hold after this Form 4?

After the reported transaction, Cynthia Burks directly holds 6,213 shares of Inspire Medical Systems common stock. This total includes the newly granted 3,562 restricted stock units, which each represent a contingent right to receive one share upon vesting under the award’s terms.

What are the vesting terms of Cynthia Burks’ 3,562 RSUs at Inspire Medical Systems (INSP)?

The 3,562 RSUs granted to Cynthia Burks vest on the earlier of the first anniversary of the grant date or immediately before a Change of Control. Vesting in both cases is conditioned on her continued service with Inspire Medical Systems through the applicable vesting date under the 2018 Incentive Award Plan.

Does Cynthia Burks pay a purchase price for the 3,562 Inspire Medical RSUs?

The filing shows a price per share of 0.0000 for the 3,562 RSUs, indicating they were awarded at no cash cost. This reflects a typical equity compensation grant, where value is delivered through future share settlement rather than an immediate cash outlay by the director.

What does each RSU granted to Cynthia Burks by Inspire Medical Systems represent?

Each RSU granted to Cynthia Burks represents a contingent right to receive one share of Inspire Medical Systems common stock. Delivery of shares occurs only if the vesting conditions are satisfied, including continued service and, if applicable, timing relative to a Change of Control event.